DK291186A - Antianafylaktiske og antibronchospastiske n-benzhydryldiazacykloalkylalkananilider - Google Patents

Antianafylaktiske og antibronchospastiske n-benzhydryldiazacykloalkylalkananilider Download PDF

Info

Publication number
DK291186A
DK291186A DK291186A DK291186A DK291186A DK 291186 A DK291186 A DK 291186A DK 291186 A DK291186 A DK 291186A DK 291186 A DK291186 A DK 291186A DK 291186 A DK291186 A DK 291186A
Authority
DK
Denmark
Prior art keywords
benzhydryldiazacycloalkylalkananilides
antibronchospastic
antianaphylactic
Prior art date
Application number
DK291186A
Other languages
Danish (da)
English (en)
Other versions
DK291186D0 (da
Inventor
Dante Nardi
Amedeo Leonardi
Gianni Motta
Pietro Cazzulani
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of DK291186D0 publication Critical patent/DK291186D0/da
Publication of DK291186A publication Critical patent/DK291186A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/06Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK291186A 1985-06-20 1986-06-20 Antianafylaktiske og antibronchospastiske n-benzhydryldiazacykloalkylalkananilider DK291186A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21225/85A IT1190375B (it) 1985-06-20 1985-06-20 N-benzidrildiazacicloalchil-alcanilidi ad attivita' antianafilattica ed antibroncospastica

Publications (2)

Publication Number Publication Date
DK291186D0 DK291186D0 (da) 1986-06-20
DK291186A true DK291186A (da) 1986-12-21

Family

ID=11178661

Family Applications (1)

Application Number Title Priority Date Filing Date
DK291186A DK291186A (da) 1985-06-20 1986-06-20 Antianafylaktiske og antibronchospastiske n-benzhydryldiazacykloalkylalkananilider

Country Status (24)

Country Link
US (1) US4675319A (no)
EP (1) EP0207901B1 (no)
JP (1) JPS61293977A (no)
KR (1) KR870000309A (no)
CN (1) CN1011784B (no)
AR (1) AR241591A1 (no)
AT (1) ATE58729T1 (no)
AU (1) AU592348B2 (no)
CA (1) CA1269980A (no)
DE (1) DE3675824D1 (no)
DK (1) DK291186A (no)
ES (1) ES8708218A1 (no)
FI (1) FI862204A (no)
GR (1) GR861391B (no)
HU (1) HU198033B (no)
IL (1) IL78804A (no)
IT (1) IT1190375B (no)
NO (1) NO163816C (no)
NZ (1) NZ216547A (no)
PH (1) PH22809A (no)
PT (1) PT82810B (no)
SG (1) SG7292G (no)
TN (1) TNSN86090A1 (no)
ZA (1) ZA863754B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0660160B2 (ja) * 1985-12-13 1994-08-10 テルモ株式会社 アミド誘導体およびこれを含有する抗アレルギ−剤
FR2601366B1 (fr) * 1986-07-10 1988-11-25 Andre Buzas Derives de la benzhydryloxyethyl-piperazine, procedes d'obtention et de compositions pharmaceutiques les contenant.
US5028610A (en) * 1987-03-18 1991-07-02 Sankyo Company Limited N-benzhydryl-substituted heterocyclic derivatives, their preparation and their use
FR2614021B1 (fr) * 1987-04-14 1991-03-01 Andre Buzas Derives de la 1-((1,1-diphenyl)-1-alcenyl)-piperazine, procede d'obtention et compositions pharmaceutiques les contenant
US4745191A (en) * 1987-09-30 1988-05-17 American Home Products Corporation 1-((A-substituted phenyl-ω-substituted piperazinyl)alkenyl) cyclohexanol
CA2113449A1 (en) * 1991-07-19 1993-02-04 Kazuhiro Kumagai Piperazine derivatives and pharmaceuticals containing the same
KR19990010329A (ko) * 1997-07-16 1999-02-18 레나르트 태퀴스트 실리콘 질화물 절삭 공구 재료
EP1101759A4 (en) 1998-07-31 2001-12-12 Nippon Soda Co PHENYLAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICATIONS FOR HYPERLIPEMY
KR100384241B1 (ko) * 2000-10-31 2003-05-16 (주) 기산테크 저활동성 플라즈마 이온 방전을 이용한 오존발생장치
DE102006047620B4 (de) 2006-10-09 2008-11-27 Clariant International Limited Verfahren zur Herstellung tertiärer Amide von Alkylphenylcarbonsäuren
DE102006047619B4 (de) * 2006-10-09 2008-11-13 Clariant International Limited Verfahren zur Herstellung basischer Fettsäureamide
DE102006047617B4 (de) * 2006-10-09 2008-11-27 Clariant International Limited Verfahren zur Herstellung basischer (Meth)acrylamide
DE102006047618B3 (de) * 2006-10-09 2007-11-15 Clariant International Limited Verfahren zur Herstellung von Bisbenzoxazolen
ES2543347T3 (es) * 2006-10-09 2015-08-18 Clariant Finance (Bvi) Limited Procedimiento para la preparación de alcanolamidas de ácidos grasos
KR101079459B1 (ko) * 2007-09-14 2011-11-03 이화여자대학교 산학협력단 신규한 화합물, 이의 제조방법 및 이를 포함하는 통증억제용 조성물
DE102008017218B4 (de) * 2008-04-04 2011-09-22 Clariant International Ltd. Kontinuierliches Verfahren zur Herstellung von Amiden niederer aliphatischer Carbonsäuren
DE102008017219A1 (de) * 2008-04-04 2009-10-08 Clariant International Ltd. Verfahren zur Herstellung von Amiden in Gegenwart von überhitztem Wasser
DE102008017217A1 (de) * 2008-04-04 2009-10-08 Clariant International Ltd. Kontinuierliches Verfahren zur Herstellung von Amiden aromatischer Carbonsäuren
DE102008017215B4 (de) * 2008-04-04 2012-08-09 Clariant International Ltd. Kontinuierliches Verfahren zur Herstellung von Amiden ethylenisch ungesättigter Carbonsäuren
DE102008017213B4 (de) * 2008-04-04 2012-08-09 Clariant International Limited Kontinuierliches Verfahren zur Herstellung von Amiden aliphatischer Hydroxycarbonsäuren
DE102008017214B4 (de) * 2008-04-04 2012-02-16 Clariant International Limited Kontinuierliches Verfahren zur Herstellung von Fettsäurealkanolamiden
DE102008017216B4 (de) * 2008-04-04 2013-08-14 Clariant International Ltd. Kontinuierliches Verfahren zur Herstellung von Fettsäureamiden
CN101429164B (zh) * 2008-11-14 2013-03-20 广西大学 左旋二苯甲基哌嗪衍生物及其制备方法
DE102009031059A1 (de) 2009-06-30 2011-01-05 Clariant International Ltd. Vorrichtung zur kontinuierlichen Durchführung chemischer Reaktionen bei hohen Temperaturen
DE102009042522A1 (de) 2009-09-22 2011-04-07 Clariant International Ltd. Kontinuierliches Umesterungsverfahren
DE102009042523B4 (de) 2009-09-22 2012-02-16 Clariant International Ltd. Vorrichtung und Verfahren zur kontinuierlichen Durchführung heterogen katalysierter chemischer Reaktionen bei hohen Temperaturen
DE102010056564A1 (de) 2010-12-30 2012-07-05 Clariant International Limited Hydroxylgruppen und Estergruppen tragende Polymere und Verfahren zu ihrer Herstellung
DE102010056565A1 (de) 2010-12-30 2012-07-05 Clariant International Ltd. Verfahren zur Modifizierung Hydroxylgruppen tragender Polymere
WO2017066705A1 (en) * 2015-10-14 2017-04-20 Aquinnah Pharmaceuticals, Inc. Compounds, compositions and methods of use against stress granules
CN114621101A (zh) * 2020-12-11 2022-06-14 李冰坚 一种3,5-二甲基-1,2-苯二胺二盐酸盐的精制方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3244718A (en) * 1964-02-17 1966-04-05 Biel John Hans Piperazine derivatives
NL137318C (no) * 1964-06-09
DE2304154A1 (de) * 1973-01-29 1974-08-01 Ichthyol Ges Cordes Hermanni & Verfahren zur herstellung von substituierten piperazin- bzw. homopiperazinderivaten
JPS5070389A (no) * 1973-10-30 1975-06-11
GB2056968A (en) * 1979-08-21 1981-03-25 Fujisawa Pharmaceutical Co Piperazine derivative, processes for the preparation thereof and pharmaceutical composition comprising the same
US4411900A (en) * 1980-01-03 1983-10-25 Fujisawa Pharmaceutical Co., Ltd. Benzhydrylpiperozinyl thiazole derivatives and pharmaceutical composition comprising the same
JPS59118765A (ja) * 1982-12-24 1984-07-09 Fujisawa Pharmaceut Co Ltd ピペラジン誘導体
GB8303946D0 (en) * 1983-02-12 1983-03-16 Recordati Chem Pharm Antihypertensive n-piperazinylalkanoylanilides
GB8320701D0 (en) * 1983-08-01 1983-09-01 Wellcome Found Chemotherapeutic agent

Also Published As

Publication number Publication date
CA1269980A (en) 1990-06-05
EP0207901A1 (en) 1987-01-07
PH22809A (en) 1988-12-27
PT82810A (en) 1986-07-01
IT8521225A0 (it) 1985-06-20
IT1190375B (it) 1988-02-16
ATE58729T1 (de) 1990-12-15
GR861391B (en) 1986-09-16
TNSN86090A1 (fr) 1990-01-01
JPS61293977A (ja) 1986-12-24
IL78804A0 (en) 1986-09-30
FI862204A (fi) 1986-12-21
AR241591A1 (es) 1992-09-30
PT82810B (pt) 1988-04-21
ZA863754B (en) 1987-01-28
NO163816B (no) 1990-04-17
ES556145A0 (es) 1987-10-01
EP0207901B1 (en) 1990-11-28
AU5882886A (en) 1986-12-24
DK291186D0 (da) 1986-06-20
SG7292G (en) 1992-03-20
NZ216547A (en) 1989-11-28
CN1011784B (zh) 1991-02-27
AU592348B2 (en) 1990-01-11
HU198033B (en) 1989-07-28
FI862204A0 (fi) 1986-05-26
NO862427L (no) 1986-12-22
CN86105641A (zh) 1987-04-01
IL78804A (en) 1991-12-15
DE3675824D1 (de) 1991-01-10
US4675319A (en) 1987-06-23
NO163816C (no) 1990-07-25
HUT43837A (en) 1987-12-28
KR870000309A (ko) 1987-02-17
NO862427D0 (no) 1986-06-18
ES8708218A1 (es) 1987-10-01

Similar Documents

Publication Publication Date Title
DK291186A (da) Antianafylaktiske og antibronchospastiske n-benzhydryldiazacykloalkylalkananilider
LU90621I2 (fr) Orbifloxacin
DK359686D0 (da) Lyofiliserede emulsionsmidler og fremgangsmaade
DK543386D0 (da) Thienooxazinoner deres fremstilling og anvendelse
DK139286D0 (da) Inden- og naphthalenderivater
DK413187D0 (da) Semicarbazoner og thiosemicarbazoner
DK406086A (da) Bbm-1675c og d-antitumor-antibiotica
DK488185A (da) N6-benzopyrano- og benzothiopyranoadenosiner
DK9886D0 (da) Naphthalenderivater og fremstilling deraf
AT386920B (de) Maishaecksler
FR2588259B1 (fr) Bis-acridiniques monopontes et bis-acridiniques bipontes
ATA122686A (de) Kettenschloss
DK363786D0 (da) Hydroquinoliner og anvendelse deraf
NO157922C (no) Fremgangsm te og gjoere brisling tefr
FR2577269B3 (fr) Ser
KR870700045A (ko) 특허수속서와 그 제조방법
RO93833A2 (ro) Solutie antiacneica si antiseboreica
IT8535592V0 (it) Custodia-scatola automontante ed autoriducibile
DK90087D0 (da) Stillads og stilladsbuk dertil
RO91513A2 (ro) Comprimate antigripale
KR870000166U (ko) 귀걸이
DK477385D0 (da) Transportoer og anvendelse heraf
DE8514008U1 (de) Anhänger
IT8508915V0 (it) Maralex in
ES288767Y (es) Pulsera

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment